Mobility and Cognitive Improvements Resulted from Overground Robotic Exoskeleton Gait-Training in Persons with MS

Author(s):  
Ghaith J. Androwis ◽  
Marek A. Kwasnica ◽  
Peter Niewrzol ◽  
Paula Popok ◽  
Farris N. Fakhoury ◽  
...  
Sensors ◽  
2021 ◽  
Vol 21 (14) ◽  
pp. 4874
Author(s):  
San-Ha Kim ◽  
Jae-Young Han ◽  
Min-Keun Song ◽  
In-Sung Choi ◽  
Hyeng-Kyu Park

Spinocerebellar ataxia (SCA) is a hereditary neurodegenerative disorder that presents as ataxia. Due to the decline in balance, patients with SCA often experience restricted mobility and a decreased quality of life. Thus, many studies have emphasized the importance of physiotherapies, including gait training, in SCA patients. However, few studies have examined the effectiveness of robotic gait training in SCA. Here, we report the therapeutic outcomes of exoskeleton-assisted gait training in a patient with SCA. A 23-year-old woman with SCA participated in a gait training program using a powered lower-limb robotic exoskeleton, ANGELLEGS. The 8-week training program consisted of standing training, weight-shifting exercises, and gait training. Several measures of general function, balance, gait, and cardiopulmonary function were applied before, after, and 4 weeks after the program. After the program, overall improvements were found on scales measuring balance and gait function, and these improvements remained at 4 weeks after the program. Cardiopulmonary function was also improved 4 weeks after the program. Robotic exoskeleton gait training can be a beneficial option for training balance, gait, and cardiopulmonary function in SCA.


2020 ◽  
pp. 135245852094308
Author(s):  
Seng Kwee Wee ◽  
Chiu Yi Ho ◽  
Si Lei Tan ◽  
Cheng Hong Ong

Wearable powered robotic exoskeleton can provide high repetitions and high-intensity gait training. It can promote a sense of well-being when the user is in upright posture to walk around different environment. We present a case of a lady with progressive multiple sclerosis who received 15 sessions of robotic exoskeleton training. Post training, she demonstrated improvement in lower limb strength, sense of well-being and self-esteem that led to improved transfer ability, increased social outings and better quality of life (QOL). Previously, she was depressed and reluctant to go out for social activities. This case suggests the potential of robotic exoskeleton to enhance QOL in people with mobility challenges.


2019 ◽  
Vol 35 (S1) ◽  
pp. 95-95
Author(s):  
Luis María Sánchez-Gómez ◽  
Ana Isabel Hijas-Gómez ◽  
Mar Polo-DeSantos ◽  
Setefilla Luengo-Matos

IntroductionThe Stride Management Assist (SMA®) device consist in a portable robotic exoskeleton designed for gait rehabilitation and training by repetition of walking patterns with automated regular gait cycles. Used for adult population with gait disorders of neurological or musculoskeletal origin that require rehabilitation. The objective of this work is to assess its efficacy and safety.MethodsThis technology was identified by the early Awareness and Alert System, “SINTESIS-new technologies” of AETS-ISCIII. An early assessment of the technology was conducted. The searched databases were: Pubmed, Embase, WOS, Tripdatabase, ClinicalTrials.org and Cochrane Library. Clinical studies using the device published in any language until 10 October 2018 were reviewed.ResultsWe found 3 abstracts to congresses and 6 clinical trials that evaluated the use of the device. Outcomes measures among studies included spatiotemporal gait parameters, energy expenditure, muscular activity and functional performance. Five studies consisted in proof-of-concept analysis; 3 studies evaluated the effect of gait training with SMA® compared with conventional therapy alone in individuals after stroke (2 studies) and Parkinson disease (1 study); and 1 before-and-after study assessed the effect of gait training with SMA® in elderly adults. During its use, improvements in spatiotemporal gait parameters were described in 4/5 studies, and 2/5 studies showed less energy expenditure versus 2/5 studies that found no differences. After gait training, 3/4 studies described greater improvements in gait parameters when associated its use. Only one clinical trial collected safety data reporting no adverse events.ConclusionsThe SMA® device allows to increase the efficiency and parameters of the march during its use. The assistance in the stride might have an impact on health by facilitating the recovery of the gait; however, further research is needed to determine the feasibility in the latter case since comparative studies with conventional therapy are limited.


2019 ◽  
Vol 15 (4) ◽  
pp. 409-417 ◽  
Author(s):  
Chad Swank ◽  
Seema Sikka ◽  
Simon Driver ◽  
Monica Bennett ◽  
Librada Callender

2017 ◽  
Vol 98 (10) ◽  
pp. e41 ◽  
Author(s):  
Melvin Mejia ◽  
Ghaith Androwis ◽  
Kathleen Chervin ◽  
Christina Cording ◽  
Adam Kesten ◽  
...  

2021 ◽  
pp. 1-11
Author(s):  
Kiran K. Karunakaran ◽  
Sharon Gute ◽  
Gregory R. Ames ◽  
Kathleen Chervin ◽  
Christina M. Dandola ◽  
...  

BACKGROUND: Stroke is a leading cause of disability resulting in long-term functional ambulation deficits. Conventional therapy can improve ambulation, but may not be able to provide consistent, high dose repetition of movement, resulting in variable recovery with residual gait deviations. OBJECTIVE: The objective of this preliminary prospective investigation is to evaluate the ability of a robotic exoskeleton (RE) to provide high dose gait training, and measure the resulting therapeutic effect on functional ambulation in adults with acute stroke. METHODS: Participants (n = 14) received standard of care (SOC) and RE overground gait training during their scheduled physical therapy (PT) sessions at the same inpatient rehabilitation facility. The outcome measures included distance walked during their PT training sessions (RE and SOC), and functional ambulation measures (10-meter walk test (10MWT), 6-minute walk test (6 MWT), and timed up and go (TUG)). RESULTS: The average total distance walked during RE and the average distance per RE session was significantly higher than SOC sessions. Total walking distance during PT (RE+SOC) showed a strong positive correlation to the total number of steps during RE sessions and number of RE sessions. All functional ambulation measures showed significant improvement at follow-up compared to baseline. The improvement in functional ambulation measures showed a positive correlation with the increase in number of RE gait training sessions. CONCLUSION: The RE can be utilized for inpatient rehabilitation in conjunction with SOC gait training sessions and may result in improved functional ambulation in adults with acute stroke. This preliminary research provides information on the ability of the robotic exoskeleton to provide high dose therapy and its therapeutic effect on functional ambulation in adults with acute stroke during inpatient rehabilitation.


2019 ◽  
Vol 100 (10) ◽  
pp. e117-e118
Author(s):  
Molly Trammell ◽  
Chad Swank ◽  
Kara Patterson ◽  
Monica Bennett ◽  
Christa Ochoa ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document